| Literature DB >> 30835428 |
Jana L Markley, Luting Fang, Andrew J Gasparrini1, Chanez T Symister, Hirdesh Kumar2, Niraj H Tolia2, Gautam Dantas1,3,4, Timothy A Wencewicz.
Abstract
The synthesis and biological evaluation of semisynthetic anhydrotetracycline analogues as small molecule inhibitors of tetracycline-inactivating enzymes are reported. Inhibitor potency was found to vary as a function of enzyme (major) and substrate-inhibitor pair (minor), and anhydrotetracycline analogue stability to enzymatic and nonenzymatic degradation in solution contributes to their ability to rescue tetracycline activity in whole cell Escherichia coli expressing tetracycline destructase enzymes. Taken collectively, these results provide the framework for the rational design of next-generation inhibitor libraries en route to a viable and proactive adjuvant approach to combat the enzymatic degradation of tetracycline antibiotics.Entities:
Keywords: Tet(X); anhydrotetracycline; antibiotic adjuvants; antibiotic resistance; enzymology; eravacycline; inactivating enzymes; omadacycline; tetracycline destructases; tetracyclines; tigecycline
Mesh:
Substances:
Year: 2019 PMID: 30835428 PMCID: PMC6490184 DOI: 10.1021/acsinfecdis.8b00349
Source DB: PubMed Journal: ACS Infect Dis ISSN: 2373-8227 Impact factor: 5.084